Related Experiment Videos
Summary
Atropine eye drops significantly slowed myopia progression in children over a four-year period. Treated eyes showed reduced myopia compared to control eyes, with lasting effects observed.
Area of Science:
- Ophthalmology
- Pediatric medicine
Background:
- Myopia, or nearsightedness, is a growing concern in children.
- Effective long-term myopia control strategies are needed.
Purpose of the Study:
- To evaluate the long-term efficacy of atropine eye drops in controlling myopia progression in children.
Main Methods:
- A crossover study involving 62 children treated with atropine in one eye for one year, followed by a switch.
- A subset of 28 patients continued treatment for four years.
Main Results:
- Control eyes exhibited significant increases in myopia compared to atropine-treated eyes.
- Some treated eyes demonstrated a decrease in myopia, while control eyes did not.
- Posttreatment analysis confirmed sustained therapeutic effects.
Conclusions:
- Atropine eye drops are an effective long-term treatment for reducing myopia progression in pediatric patients.
- The observed benefits of atropine treatment for myopia control are durable.